Cadrenal Therapeutics, Inc. · NASDAQ:CVKD

Pham Quang X sold 1,165 Cadrenal Therapeutics, Inc. shares (Form 4)

Traded May 22, 2026 · Filed May 26, 2026

On May 22, 2026, Pham Quang X (Director, CEO and Chairman, 10% owner) sold 1,165 Cadrenal Therapeutics, Inc. shares at US$5.69 for US$6,629 under a trading plan, leaving 194,924 shares. Filed May 26, 2026 (Form 4).

Sold
1,165 shares
Price
US$5.69
Value
US$6,629
Holding after
194,924 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CEO and Chairman, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 22, 2026Common StockSale1,165US$5.69194,924Direct

Source

View original at SEC

Related